The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the treatment of many urologic cancers. Patients and clinicians should consider the oncologic risk of delayed cancer intervention versus the risks of COVID-19 to patients, treating health care professionals, and the health care system.
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic[Formula presented]
Necchi A.;
2020-01-01
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the treatment of many urologic cancers. Patients and clinicians should consider the oncologic risk of delayed cancer intervention versus the risks of COVID-19 to patients, treating health care professionals, and the health care system.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
